Not logged in.png)
Share.png)
SavePredicting a high-grade pattern in IASLC grading system of lung adenocarcinoma using 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging combined with clinical features: a nomogram approach
Fu, S.; Sun, J.; You, J.; Zhou, W.; Dong, Q.; Cheng, J.; Hu, D.; Wang, Y.; Lu, M.; Chen, X. Share Save Share Save More than meets the eye: predicting adrenocortical carcinoma outcomes with pathomicsKong, Jianqiu; Luo, Mingli; Huang, Yi; Lin, Ying; Tan, Kaiwen; Zou, Yitong; Yong, Juanjuan; Fu, Sha; Zhang, Shaoling; Fan, Xinxiang; Lin, Tianxin Share Save Share Save N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failureLu, Yi; Chen, Junzhe; Su, Licong; Lukwaro, Andrew Fanuel; Zhou, Shiyu; Zheng, Shaoxin; Luo, Yuxin; Fu, Sha; Nie, Sheng; Tang, Ying Share Save Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trialsZhou, Yixin; Yu, Hui; Chen, Chen; Li, Anlin; Zhang, Xuanye; Qiu, Huijuan; Du, Wei; Fu, Sha; Zhang, Li; Hong, Shaodong Share Save Efficacy and safety of cadonilimab combined albumin-paclitaxel, cisplatin and fluorouracil (APF) in neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC): Results from the CAPITAL trialMiao, H.; Fu, S.; Ruan, L.; Gao, Y.; Zhu, X.; Zhou, J.; Fang, W.; Xu, H.; Liu, L. Share Save Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancerWang, Jue; Yu, Yunfang; Tan, Yujie; Wan, Huan; Zheng, Nafen; He, Zifan; Mao, Luhui; Ren, Wei; Chen, Kai; Lin, Zhen; He, Gui; Chen, Yongjian; Chen, Ruichao; Xu, Hui; Liu, Kai; Yao, Qinyue; Fu, Sha; Song, Yang; Chen, Qingyu; Zuo, Lina; Wei, Liya; Wang, Jin; Ouyang, Nengtai; Yao, Herui Share Save TP53-specific mutations serve as a potential biomarker for homologous recombination deficiency in breast cancer: a clinical next-generation sequencing studyHuang, Yongsheng; Ren, Shuwei; Ding, Linxiaoxiao; Jiang, Yuanling; Luo, Jiahuan; Huang, Jinghua; Yin, Xinke; Zhao, Jianli; Fu, Sha; Liao, Jianwei Share Save Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing studyHuang, Yongsheng; Qiu, Yuntan; Ding, Linxiaoxiao; Ren, Shuwei; Jiang, Yuanling; Luo, Jiahuan; Huang, Jinghua; Yin, Xinke; Fu, Sha; Zhao, Jianli; Hu, Kaishun; Liao, Jianwei Share Save Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitorHe, Li-Na; Chen, Tao; Fu, Sha; Jiang, Yongluo; Zhang, Xuanye; Chen, Chen; Du, Wei; Luo, Linfeng; Li, Anlin; Wang, Yixing; Yu, Hui; Zhou, Yixin; Wang, Yuhong; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Fang, Wenfeng; Zhang, Li; Hong, Shaodong Share Save Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancerHe, Xing; Peng, Yaorong; He, Gui; Ye, Huilin; Liu, Liqiang; Zhou, Qixian; Shi, Juanyi; Fu, Sha; Wang, Jie; Zhou, Zhenyu; Li, Wenbin Share Save Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacyLi, Anlin; Luo, Linfeng; Du, Wei; Yu, Zhixin; He, Lina; Fu, Sha; Wang, Yuanyuan; Zhou, Yixin; Yang, Chunlong; Yang, Yunpeng; Fang, Wenfeng; Zhang, Li; Hong, Shaodong Share Save ASO Visual Abstract: Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers-A Retrospective, Multicenter Cohort StudyYang, Libo; Liu, Yuqiong; Han, Dandan; Fu, Sha; Guo, Shuangping; Bao, Longlong; Shi, Yi; Huang, Rongfang; Wan, Huan; Li, Wencai; Wang, Zhe; Zhou, Xiaoyan; Chen, Gang; Liu, Yueping; Ye, Feng Share Save Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancerWang, Yixing; Fu, Sha; Zhang, Xuanye; Du, Wei; Luo, Linfeng; Jiang, Yongluo; Zhou, Yixin; Zhao, Yuanyuan; Yang, Yunpeng; Zhao, Hongyun; Fang, Wenfeng; Huang, Yan; Zhang, Li; Hong, Shaodong Share Save Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers: A Retrospective, Multicenter Cohort StudyYang, Libo; Liu, Yuqiong; Han, DanDan; Fu, Sha; Guo, Shuangping; Bao, Longlong; Shi, Yi; Huang, Rongfang; Wan, Huan; Li, Wencai; Wang, Zhe; Zhou, Xiaoyan; Chen, Gang; Liu, Yueping; Ye, Feng Share Save Share Save Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitorHe, L-N; Fu, S.; Ma, H.; Chen, C.; Zhang, X.; Li, H.; Du, W.; Chen, T.; Jiang, Y.; Wang, Y.; Wang, Y.; Zhou, Y.; Lin, Z.; Yang, Y.; Huang, Y.; Zhao, H.; Fang, W.; Zhang, H.; Zhang, L.; Hong, S. Share Save [Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancerLuo, Linfeng; Li, Anlin; Fu, Sha; Du, Wei; He, Li-Na; Zhang, Xuanye; Wang, Yixing; Zhou, Yixin; Yunpeng, Yang; Li, Zhang; Hong, Shaodong Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
